arrow
K

Krystyna Dobrowolska

Jan Kochanowski University
H指数:11
被引数:387

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictors of Severe Outcomes in COVID-19: Evidence from Real-World Multicenter Retrospective Study (2020–2024)

新型冠状病毒肺炎严重结局的预测因素: 来自真实世界多中心回顾性研究的证据 (2020-2024)

2026-02-040
OAAI
Differences in the clinical course of COVID-19 in children and adolescents hospitalized in the 2023/2024 and 2024/2025 seasons – a retrospective real-world study

2023/2024和2024/2025季节住院儿童和青少年COVID-19临床病程的差异——一项回顾性真实世界研究

2025-12-130
OAAI
Clinical characteristics of patients with primary biliary cholangitis treated with ursodeoxycholic acid

原发性胆汁性胆管炎患者使用熊去氧胆酸治疗后的临床特征

2025-09-290
OAAI
Differences in the Clinical Course of COVID-19 in Patients Hospitalized in the 2023-2024 and 2024-2025 Seasons

2023-2024和2024-2025季节住院患者中COVID-19临床病程的差异

2025-08-250
PRE
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland

在战争难民涌入波兰期间,乌克兰裔患者中丙型肝炎病毒感染的治疗

2024-12-150
OAAI
Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up and effectiveness of antiviral therapy

治疗慢性丙型肝炎患者的乙型肝炎病毒合并感染: 临床特征,长期随访的再激活风险和抗病毒治疗的有效性

2024-01-023
OA
Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant

Omicron SARS-CoV-2变体优势的早期和晚期之间住院新型冠状病毒肺炎患者的临床表现变化

2023-08-2612
OAAI
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders

在丙型肝炎病毒精神障碍患者中直接抗病毒药物的真实世界有效性和安全性

2023-07-076
OAAI